IBDEI0PT ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11603,2)
 ;;=^5015588
 ;;^UTILITY(U,$J,358.3,11604,0)
 ;;=R33.8^^46^561^23
 ;;^UTILITY(U,$J,358.3,11604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11604,1,3,0)
 ;;=3^Urinary Retention,Other
 ;;^UTILITY(U,$J,358.3,11604,1,4,0)
 ;;=4^R33.8
 ;;^UTILITY(U,$J,358.3,11604,2)
 ;;=^5019331
 ;;^UTILITY(U,$J,358.3,11605,0)
 ;;=R39.15^^46^561^26
 ;;^UTILITY(U,$J,358.3,11605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11605,1,3,0)
 ;;=3^Urinary Urgency
 ;;^UTILITY(U,$J,358.3,11605,1,4,0)
 ;;=4^R39.15
 ;;^UTILITY(U,$J,358.3,11605,2)
 ;;=^5019345
 ;;^UTILITY(U,$J,358.3,11606,0)
 ;;=R39.12^^46^561^27
 ;;^UTILITY(U,$J,358.3,11606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11606,1,3,0)
 ;;=3^Weak Urinary Stream
 ;;^UTILITY(U,$J,358.3,11606,1,4,0)
 ;;=4^R39.12
 ;;^UTILITY(U,$J,358.3,11606,2)
 ;;=^5019342
 ;;^UTILITY(U,$J,358.3,11607,0)
 ;;=R80.9^^46^561^17
 ;;^UTILITY(U,$J,358.3,11607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11607,1,3,0)
 ;;=3^Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,11607,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,11607,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,11608,0)
 ;;=R31.21^^46^561^10
 ;;^UTILITY(U,$J,358.3,11608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11608,1,3,0)
 ;;=3^Microscopic Hematuria,Asymptomatic
 ;;^UTILITY(U,$J,358.3,11608,1,4,0)
 ;;=4^R31.21
 ;;^UTILITY(U,$J,358.3,11608,2)
 ;;=^5139198
 ;;^UTILITY(U,$J,358.3,11609,0)
 ;;=R31.29^^46^561^11
 ;;^UTILITY(U,$J,358.3,11609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11609,1,3,0)
 ;;=3^Microscopic Hematuria,Other
 ;;^UTILITY(U,$J,358.3,11609,1,4,0)
 ;;=4^R31.29
 ;;^UTILITY(U,$J,358.3,11609,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,11610,0)
 ;;=R33.9^^46^561^24
 ;;^UTILITY(U,$J,358.3,11610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11610,1,3,0)
 ;;=3^Urinary Retention,Unspec
 ;;^UTILITY(U,$J,358.3,11610,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,11610,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,11611,0)
 ;;=R35.89^^46^561^15
 ;;^UTILITY(U,$J,358.3,11611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11611,1,3,0)
 ;;=3^Polyuria,Other
 ;;^UTILITY(U,$J,358.3,11611,1,4,0)
 ;;=4^R35.89
 ;;^UTILITY(U,$J,358.3,11611,2)
 ;;=^5161234
 ;;^UTILITY(U,$J,358.3,11612,0)
 ;;=D51.8^^46^562^2
 ;;^UTILITY(U,$J,358.3,11612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11612,1,3,0)
 ;;=3^Anemia,Vitamin B12 Deficiency
 ;;^UTILITY(U,$J,358.3,11612,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,11612,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,11613,0)
 ;;=D52.9^^46^562^1
 ;;^UTILITY(U,$J,358.3,11613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11613,1,3,0)
 ;;=3^Anemia,Folate Deficiency
 ;;^UTILITY(U,$J,358.3,11613,1,4,0)
 ;;=4^D52.9
 ;;^UTILITY(U,$J,358.3,11613,2)
 ;;=^5002293
 ;;^UTILITY(U,$J,358.3,11614,0)
 ;;=I10.^^46^563^12
 ;;^UTILITY(U,$J,358.3,11614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11614,1,3,0)
 ;;=3^Hypertension,Essential
 ;;^UTILITY(U,$J,358.3,11614,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,11614,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,11615,0)
 ;;=I15.0^^46^563^13
 ;;^UTILITY(U,$J,358.3,11615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11615,1,3,0)
 ;;=3^Hypertension,Renovascular
 ;;^UTILITY(U,$J,358.3,11615,1,4,0)
 ;;=4^I15.0
 ;;^UTILITY(U,$J,358.3,11615,2)
 ;;=^5007071
 ;;^UTILITY(U,$J,358.3,11616,0)
 ;;=I13.11^^46^563^8
 ;;^UTILITY(U,$J,358.3,11616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11616,1,3,0)
 ;;=3^HTN Hrt & CKD w/o Hrt Failure w/ Stage 5 Chr Kidney/ESRD
